by McDermott + Bull | Jul 28, 2021 | Investor Insights, Ken Dropiewski, Video
This week, host Ken Dropiewski interviews Paul LaViolette, Managing Partner and Chief Operating Officer of SV Health Investors. They discuss a range of topics, from the timing of investments to important ideas facing the industry. SEE MORE INSIGHTS FROM TOP...
by McDermott + Bull | Jun 2, 2021 | Article, Ken Dropiewski
THE NEW NORMAL: WHAT BUSINESS TRAVEL WILL LOOK LIKE FOR EXECUTIVES Over the past six months, I’ve had the opportunity to speak with executives in the life science and medtech space about the reduction in business travel due to the pandemic. We talked about what it has...
by McDermott + Bull | May 26, 2021 | Investor Insights, Ken Dropiewski, Video
In this episode of Investor Insights, McDermott + Bull Partner Ken Dropiewski sits down with Managing Director Joe Biller of 3×5 Partners to discuss portfolio companies, investment opportunities, and new technologies in the MedTech + Life Sciences space. SEE MORE...
by McDermott + Bull | May 17, 2021 | Chris Bull, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Ken Dropiewski Placement Announcement, Placement Announcement
McDermott + Bull has successfully placed Navesh Kandiyil as the Vice President of Respiratory Business + Clinical Programs for Apria Healthcare. As the Vice President of Respiratory Business + Clinical Programs, Navesh will focus on the overall strategy, growth, and...
by McDermott + Bull | Apr 29, 2021 | Investor Insights, Ken Dropiewski, Video
In this episode of Investor Insights, McDermott + Bull Partner Ken Dropiewski sits down with General Partner Jason Lettmann about Lightstone Ventures and the MedTech industry in Colorado. SEE MORE INSIGHTS FROM TOP...
by McDermott + Bull | Apr 15, 2021 | Chris Bull, Healthcare + Life Sciences Placement Announcement, Ken Dropiewski, Placement Announcement
McDermott + Bull has successfully placed Steven Cha as the Chief Medical Officer at NKMax America, Inc. Steven will provide leadership and direction for the company’s pipeline of clinical development programs in cellular therapy. He will be a key member of the senior...
